Corrigendum: The GIP Gamma-Tubulin Complex-Associated Proteins are Involved in Nuclear Architecture in Arabidopsis Thaliana

Corrigendum: The GIP Gamma-Tubulin Complex-Associated Proteins are Involved in Nuclear Architecture in Arabidopsis Thaliana

Bibliographic Details
Main Authors:	Morgane Batzenschlager, Kinda Masoud, Natacha Janski, Guy Houlné, Etienne Herzog, Jean-Luc Evrard, Nicolas Baumberger, Mathieu Erhardt, Yves Nominé, Bruno Kieffer, Anne-Catherine Schmit, Marie-Edith Chabouté
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-09-01
Series:	Frontiers in Plant Science
Subjects:	gamma-tubulin complex AtGIP1/MOZART1 AtTSA1 nuclear envelope Arabidopsis thaliana
Online Access:	https://www.frontiersin.org/article/10.3389/fpls.2020.589954/full

Similar Items

The GIP gamma-tubulin complex-associated proteins are involved in nuclear architecture in Arabidopsis thaliana.
by: Morgane eBatzenschlager, et al.
Published: (2013-11-01)

GIP1 and GIP2 Contribute to the Maintenance of Genome Stability at the Nuclear Periphery
by: Gaurav Singh, et al.
Published: (2022-01-01)

GIP/MZT1 proteins orchestrate nuclear shaping
by: Morgane eBatzenschlager, et al.
Published: (2014-02-01)

Contribution of GIP and GLP-1 to the Insulin Response to Oral Administration of Glucose in Female Mice
by: Bo Ahrén
Published: (2023-02-01)

GLP1 and GIP are involved in the action of synbiotics in broiler chickens
by: Pawel Antoni Kolodziejski, et al.
Published: (2018-01-01)

GIP_HUMAN [22–51] Peptide Encoded by the Glucose-Dependent Insulinotropic Polypeptide (GIP) Gene Suppresses Insulin Expression and Secretion in INS-1E Cells and Rat Pancreatic Islets
by: Emily Pusch, et al.
Published: (2023-10-01)

GIP contributions to the regulation of centromere at the interface between the nuclear envelope and the nucleoplasm.
by: Marie-Edith eChabouté, et al.
Published: (2016-02-01)

Glucose-dependent insulinotropic polypeptide (GIP) and GIP receptor (GIPR) genes: An association analysis of polymorphisms and bone in young and elderly women
by: Gaurav Garg, et al.
Published: (2016-06-01)

Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice
by: Patrick J. Knerr, et al.
Published: (2022-09-01)

The Role of GLP-1, GIP, MCP-1 and IGFBP-7 Biomarkers in the Development of Metabolic Disorders: A Review and Predictive Analysis in the Context of Diabetes and Obesity
by: Malwina Jędrysik, et al.
Published: (2024-01-01)

Loss of GIPR in LEPR cells impairs glucose control by GIP and GIP:GLP-1 co-agonism without affecting body weight and food intake in mice
by: Seun Akindehin, et al.
Published: (2024-05-01)

Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH Realms
by: Othman Al Musaimi
Published: (2024-02-01)

Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males
by: Dorte B. Zilstorff, et al.
Published: (2024-03-01)

Dysglycemia Shapes Visceral Adipose Tissue’s Response to GIP, GLP-1 and Glucagon in Individuals with Obesity
by: Tiago Morais, et al.
Published: (2023-04-01)

GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease
by: Stephan Sachs, et al.
Published: (2023-08-01)

Nephroprotective Properties of the Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) Receptor Agonists
by: Tomislav Bulum
Published: (2022-10-01)

Bumps and humps in the success of Tirzepatide as the first GLP1 and GIP receptor agonist
by: Rouchan Ali, et al.
Published: (2022-09-01)

Saponins from <i>Camellia sinensis</i> Seeds Stimulate GIP Secretion in Mice and STC-1 Cells via SGLT1 and TGR5
by: Huanqing Zhu, et al.
Published: (2022-08-01)

Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats
by: Sara Baldassano, et al.
Published: (2019-08-01)

Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP
by: Wang L
Published: (2022-05-01)

Dual GIP–GLP1-Receptor Agonists In The Treatment Of Type 2 Diabetes: A Short Review On Emerging Data And Therapeutic Potential
by: Bastin M, et al.
Published: (2019-09-01)

The Game of Tubulins
by: Maria Alvarado Kristensson
Published: (2021-03-01)

GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced Obesity Mice
by: Nakamura T, et al.
Published: (2021-03-01)

Deciphering the Tubulin Language: Molecular Determinants and Readout Mechanisms of the Tubulin Code in Neurons
by: Riccardo Zocchi, et al.
Published: (2023-02-01)

Expression and localization of alpha-tubulin N-acetyltransferase 1 in the reproductive system of male mice
by: Rin YANAI, et al.
Published: (2020-12-01)

Inhibition of Polo-like Kinase 1 Prevents the Male Pronuclear Formation Via Alpha-tubulin Recruiting in In Vivo-fertilized Murine Embryos
by: Jeonghyeon Moon, et al.
Published: (2018-12-01)

Tubulin Isotypes: Emerging Roles in Defining Cancer Stem Cell Niche
by: Tessy Thomas Maliekal, et al.
Published: (2022-05-01)

Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment
by: Maria Chiara Pelle, et al.
Published: (2021-12-01)

Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
by: Qian Zhou, et al.
Published: (2023-10-01)

Tubulin and Tubulin Posttranslational Modifications in Alzheimer’s Disease and Vascular Dementia
by: Estibaliz Santiago-Mujika, et al.
Published: (2021-10-01)

The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect
by: Enrique Z. Fisman, et al.
Published: (2021-11-01)

Basal insulin intensification with GLP-1RA and dual GIP and GLP-1RA in patients with uncontrolled type 2 diabetes mellitus: A rapid review of randomized controlled trials and meta-analysis
by: Giuseppe Lisco, et al.
Published: (2022-09-01)

The Amazing Evolutionary Complexity of Eukaryotic Tubulins: Lessons from Naegleria and the Multi-tubulin Hypothesis
by: Chandler Fulton
Published: (2022-04-01)

Colchicine Blocks Tubulin Heterodimer Recycling by Tubulin Cofactors TBCA, TBCB, and TBCE
by: Sofia Nolasco, et al.
Published: (2021-04-01)

Incretin Hormones and Type 2 Diabetes—Mechanistic Insights and Therapeutic Approaches
by: Geke Aline Boer, et al.
Published: (2020-12-01)

Incretin hormones as immunomodulators of atherosclerosis
by: Nuria eAlonso, et al.
Published: (2012-09-01)

The Tubulin Code and Tubulin-Modifying Enzymes in Autophagy and Cancer
by: Daniela Trisciuoglio, et al.
Published: (2021-12-01)

γ-Tubulin in microtubule nucleation and beyond
by: Vadym Sulimenko, et al.
Published: (2022-09-01)

Reconstituting Microtubules: A Decades-Long Effort From Building Block Identification to the Generation of Recombinant α/β-Tubulin
by: Shih-Chieh Ti
Published: (2022-04-01)

Noninvasive Evaluation of GIP Effects on β-Cell Mass Under High-Fat Diet
by: Sakura Kiyobayashi, et al.
Published: (2022-07-01)